SCHEMBL278978

SCHEMBL278978

C=C(/N=C/c1cc(Br)ccc1OC1CCOCC1)O[Si](C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.36
HPGD P15428 3/20 0.36
TSHR P16473 1/20 0.36
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 3/20 0.34
PDE4D Q08499 8/20 0.34
PDE4B Q07343 6/20 0.34
PDE4A P27815 5/20 0.34
PDE4C Q08493 5/20 0.34
KAT2B Q92831 1/20 0.34
BAZ2B Q9UIF8 1/20 0.34
AMY1A P0DUB6 1/20 0.34
LMNA P02545 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.32
NPC1 O15118 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL278977 0.87 SYK (0.36) SYKPDE4DPDE4BPDE4APDE4C
SCHEMBL276886 0.87 SYK (0.36) SYKPDE4DPDE4BPDE4APDE4C
SCHEMBL279161 0.87 SYK (0.39) SYKPDE4DPDE4BPDE4APDE4C
SCHEMBL276376 0.87 SYK (0.39) SYKPDE4DPDE4BPDE4APDE4C
SCHEMBL278931 0.87 CHEK1 (0.38) SYKHPGDTSHRPDE4DPDE4B
SCHEMBL275247 0.87 CHEK1 (0.38) SYKHPGDTSHRPDE4DPDE4B
SCHEMBL279056 0.80 PDE4B (0.44) PDE4DPDE4BPDE4APDE4C
SCHEMBL279214 0.78 EGFR (0.35) SYKKAT2BBAZ2B
SCHEMBL274398 0.77 PDE4D (0.36) PDE4DPDE4BPDE4APDE4C
SCHEMBL279473 0.77 PDE4D (0.36) PDE4DPDE4BPDE4APDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8134001-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2012-03-13 US disclosed
US-20090156610-A1 Spiroindolinone Derivatives DING QINGJIE 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156610-A1 Spiroindolinone Derivatives SDHA, AR, XPOT SYK 2511/4885HPGD 482/4885TSHR 1261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.